In our study, WIF1 levels were down-regulated almost 20-fold in GBM tissue relative to non-neoplastic brain tissue, and over 3-fold down-regulated in short surviving GBM patients, relative to longer surviving counterparts (Table 3). The gene discussed is WIF1; the disease is glioblastoma.